Qiagen Nv Stock Price To Earning

QGEN Stock

USD 43.25 0.47 1.10%

Qiagen NV fundamentals help investors to digest information that contributes to Qiagen NV's financial success or failures. It also enables traders to predict the movement of Qiagen Stock. The fundamental analysis module provides a way to measure Qiagen NV's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Qiagen NV stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Qiagen NV Company Price To Earning Analysis

Qiagen NV's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

P/E

Market Value Per Share

Earnings Per Share

More About Price To Earning | All Equity Analysis

Current Qiagen NV Price To Earning

24.32 X

Most of Qiagen NV's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Qiagen NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Qiagen Price To Earning Driver Correlations

Understanding the fundamental principles of building solid financial models for Qiagen NV is extremely important. It helps to project a fair market value of Qiagen Stock properly, considering its historical fundamentals such as Price To Earning. Since Qiagen NV's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Qiagen NV's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Qiagen NV's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Short Term Investments	Intangible Assets	Current Deferred Revenue	Long Term Debt	Property Plant Equipment	Good Will	Treasury Stock	Long Term Investments	Short Long Term Debt	Net Tangible Assets	Deferred Long Term Liab	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.69	0.89	0.46	0.89	0.73	0.91	0.77	0.43	0.83	0.46	0.53	0.74	0.78	0.96	0.9	-0.5	-0.12	-0.36	-0.02	-0.65	0.5	-0.01	0.43	-0.28	0.1
Total Stockholder Equity	0.69		0.45	0.88	0.56	0.86	0.48	0.79	0.57	0.76	0.6	0.46	0.81	0.41	0.73	0.9	-0.33	-0.21	-0.19	0.49	-0.47	0.46	0.41	0.64	-0.29	-0.54
Net Debt	0.89	0.45		0.27	0.88	0.65	0.97	0.71	0.31	0.59	0.43	0.35	0.7	0.91	0.87	0.76	-0.57	-0.06	-0.61	-0.25	-0.73	0.6	-0.19	0.35	-0.34	0.14
Retained Earnings	0.46	0.88	0.27		0.38	0.73	0.29	0.79	0.7	0.41	0.79	0.06	0.78	0.19	0.54	0.67	-0.18	-0.35	-0.15	0.76	-0.46	0.54	0.6	0.85	-0.27	-0.74
Accounts Payable	0.89	0.56	0.88	0.38		0.69	0.9	0.71	0.46	0.61	0.38	0.5	0.71	0.7	0.92	0.81	-0.26	-0.3	-0.39	-0.17	-0.71	0.47	0.03	0.5	-0.45	0.06
Net Receivables	0.73	0.86	0.65	0.73	0.69		0.69	0.85	0.66	0.64	0.45	0.36	0.82	0.59	0.82	0.9	-0.41	-0.11	-0.38	0.19	-0.7	0.69	0.34	0.62	-0.63	-0.54
Total Liab	0.91	0.48	0.97	0.29	0.9	0.69		0.77	0.44	0.59	0.4	0.36	0.67	0.89	0.88	0.78	-0.54	-0.03	-0.53	-0.22	-0.77	0.63	-0.18	0.41	-0.41	0.14
Total Current Assets	0.77	0.79	0.71	0.79	0.71	0.85	0.77		0.77	0.49	0.77	0.1	0.85	0.66	0.78	0.82	-0.46	-0.14	-0.46	0.37	-0.78	0.81	0.2	0.82	-0.46	-0.43
Short Term Debt	0.43	0.57	0.31	0.7	0.46	0.66	0.44	0.77		0.16	0.5	-0.14	0.62	0.13	0.48	0.5	-0.19	-0.19	-0.09	0.5	-0.61	0.6	0.43	0.82	-0.68	-0.51
Common Stock	0.83	0.76	0.59	0.41	0.61	0.64	0.59	0.49	0.16		0.21	0.78	0.57	0.56	0.78	0.87	-0.44	0.01	-0.14	0.02	-0.31	0.18	0.06	0.13	-0.07	0.04
Short Term Investments	0.46	0.6	0.43	0.79	0.38	0.45	0.4	0.77	0.5	0.21		-0.18	0.69	0.4	0.44	0.49	-0.25	-0.26	-0.43	0.62	-0.47	0.64	0.17	0.76	0.0	-0.41
Intangible Assets	0.53	0.46	0.35	0.06	0.5	0.36	0.36	0.1	-0.14	0.78	-0.18		0.23	0.33	0.52	0.59	-0.09	-0.15	-0.09	-0.34	0.07	-0.21	-0.06	-0.15	-0.02	0.21
Current Deferred Revenue	0.74	0.81	0.7	0.78	0.71	0.82	0.67	0.85	0.62	0.57	0.69	0.23		0.57	0.82	0.84	-0.54	-0.33	-0.36	0.36	-0.68	0.57	0.3	0.73	-0.39	-0.4
Long Term Debt	0.78	0.41	0.91	0.19	0.7	0.59	0.89	0.66	0.13	0.56	0.4	0.33	0.57		0.73	0.71	-0.63	0.14	-0.65	-0.29	-0.64	0.61	-0.38	0.21	-0.19	0.13
Property Plant Equipment	0.96	0.73	0.87	0.54	0.92	0.82	0.88	0.78	0.48	0.78	0.44	0.52	0.82	0.73		0.92	-0.44	-0.27	-0.36	0.02	-0.69	0.53	0.16	0.53	-0.38	-0.06
Good Will	0.9	0.9	0.76	0.67	0.81	0.9	0.78	0.82	0.5	0.87	0.49	0.59	0.84	0.71	0.92		-0.49	-0.13	-0.35	0.14	-0.64	0.53	0.17	0.52	-0.38	-0.26
Treasury Stock	-0.5	-0.33	-0.57	-0.18	-0.26	-0.41	-0.54	-0.46	-0.19	-0.44	-0.25	-0.09	-0.54	-0.63	-0.44	-0.49		-0.3	0.32	0.01	0.44	-0.32	0.15	-0.14	0.09	-0.03
Long Term Investments	-0.12	-0.21	-0.06	-0.35	-0.3	-0.11	-0.03	-0.14	-0.19	0.01	-0.26	-0.15	-0.33	0.14	-0.27	-0.13	-0.3		-0.01	-0.32	-0.03	0.04	-0.37	-0.5	-0.1	0.2
Short Long Term Debt	-0.36	-0.19	-0.61	-0.15	-0.39	-0.38	-0.53	-0.46	-0.09	-0.14	-0.43	-0.09	-0.36	-0.65	-0.36	-0.35	0.32	-0.01		0.26	0.25	-0.6	0.22	-0.19	0.17	0.11
Net Tangible Assets	-0.02	0.49	-0.25	0.76	-0.17	0.19	-0.22	0.37	0.5	0.02	0.62	-0.34	0.36	-0.29	0.02	0.14	0.01	-0.32	0.26		-0.08	0.21	0.53	0.64	0.13	-0.61
Deferred Long Term Liab	-0.65	-0.47	-0.73	-0.46	-0.71	-0.7	-0.77	-0.78	-0.61	-0.31	-0.47	0.07	-0.68	-0.64	-0.69	-0.64	0.44	-0.03	0.25	-0.08		-0.67	-0.17	-0.62	0.57	0.24
Long Term Debt Total	0.5	0.46	0.6	0.54	0.47	0.69	0.63	0.81	0.6	0.18	0.64	-0.21	0.57	0.61	0.53	0.53	-0.32	0.04	-0.6	0.21	-0.67		0.05	0.62	-0.43	-0.44
Capital Surpluse	-0.01	0.41	-0.19	0.6	0.03	0.34	-0.18	0.2	0.43	0.06	0.17	-0.06	0.3	-0.38	0.16	0.17	0.15	-0.37	0.22	0.53	-0.17	0.05		0.53	-0.22	-0.68
Net Invested Capital	0.43	0.64	0.35	0.85	0.5	0.62	0.41	0.82	0.82	0.13	0.76	-0.15	0.73	0.21	0.53	0.52	-0.14	-0.5	-0.19	0.64	-0.62	0.62	0.53		-0.34	-0.61
Net Working Capital	-0.28	-0.29	-0.34	-0.27	-0.45	-0.63	-0.41	-0.46	-0.68	-0.07	0.0	-0.02	-0.39	-0.19	-0.38	-0.38	0.09	-0.1	0.17	0.13	0.57	-0.43	-0.22	-0.34		0.35
Capital Stock	0.1	-0.54	0.14	-0.74	0.06	-0.54	0.14	-0.43	-0.51	0.04	-0.41	0.21	-0.4	0.13	-0.06	-0.26	-0.03	0.2	0.11	-0.61	0.24	-0.44	-0.68	-0.61	0.35

Click cells to compare fundamentals

Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.

Competition

Predict Qiagen NV

Qiagen Retained Earnings

Retained Earnings

2.58 Billion

At this time, Qiagen NV's Retained Earnings are very stable compared to the past year.

Based on the latest financial disclosure, Qiagen NV has a Price To Earning of 24.32 times. This is 5.88% lower than that of the Life Sciences Tools & Services sector and 6.64% lower than that of the Health Care industry. The price to earning for all United States stocks is 15.32% higher than that of the company.

Qiagen Price To Earning Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Qiagen NV's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Qiagen NV could also be used in its relative valuation, which is a method of valuing Qiagen NV by comparing valuation metrics of similar companies.

Qiagen NV is currently under evaluation in price to earning category among its peers.

Qiagen NV Current Valuation Drivers

We derive many important indicators used in calculating different scores of Qiagen NV from analyzing Qiagen NV's financial statements. These drivers represent accounts that assess Qiagen NV's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Qiagen NV's important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	7.4B	11.7B	12.3B	11.0B	9.9B	10.4B
Enterprise Value	8.5B	13.1B	13.4B	12.1B	10.9B	11.4B

Qiagen NV ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Qiagen NV's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Qiagen NV's managers, analysts, and investors.

Environmental

Governance

Social

Qiagen Fundamentals

	Return On Equity	0.0257
	Return On Asset	0.0484
	Profit Margin	0.05 %
	Operating Margin	0.26 %
	Current Valuation	9.95 B
	Shares Outstanding	222.26 M
	Shares Owned By Insiders	2.24 %
	Shares Owned By Institutions	87.72 %
	Number Of Shares Shorted	3.57 M
	Price To Earning	24.32 X
	Price To Book	2.69 X
	Price To Sales	4.84 X
	Revenue	1.97 B
	Gross Profit	1.44 B
	EBITDA	650.58 M
	Net Income	341.3 M
	Cash And Equivalents	1.89 B
	Cash Per Share	8.31 X
	Total Debt	1.61 B
	Debt To Equity	0.69 %
	Current Ratio	1.84 X
	Book Value Per Share	15.88 X
	Cash Flow From Operations	459.45 M
	Short Ratio	3.62 X
	Earnings Per Share	0.44 X
	Price To Earnings To Growth	0.99 X
	Target Price	50.59
	Number Of Employees	5.8 K
	Beta	0.4
	Market Capitalization	9.51 B
	Total Asset	6.12 B
	Retained Earnings	2.46 B
	Working Capital	1.07 B
	Current Asset	193.04 M
	Current Liabilities	81.49 M
	Annual Yield	0.03 %
	Net Asset	6.12 B

About Qiagen NV Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Qiagen NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Qiagen NV using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Qiagen NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with Qiagen NV

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Qiagen NV position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qiagen NV will appreciate offsetting losses from the drop in the long position's value.

Moving together with Qiagen Stock

0.65	A	Agilent Technologies	Pair Corr
0.77	ME	23Andme Holding	Pair Corr
0.7	VALN	Valneva SE ADR	Pair Corr

Moving against Qiagen Stock

0.76	EWTX	Edgewise Therapeutics	Pair Corr
0.74	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.57	EXEL	Exelixis	Pair Corr
0.52	FLGC	Flora Growth Corp	Pair Corr
0.47	KTTAW	Pasithea Therapeutics	Pair Corr

The ability to find closely correlated positions to Qiagen NV could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Qiagen NV when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Qiagen NV - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Qiagen NV to buy it.

The correlation of Qiagen NV is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Qiagen NV moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Qiagen NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Qiagen NV can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Qiagen NV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Qiagen NV's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Qiagen Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Qiagen Nv Stock:

How To Invest In Qiagen

Details

Is Qiagen Stock a good investment?

Details

What is Qiagen NV's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Qiagen NV Piotroski F Score and Qiagen NV Altman Z Score analysis.

To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.

You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Qiagen NV. If investors know Qiagen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Qiagen NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.255

Earnings Share

0.44

Revenue Per Share

8.841

Quarterly Revenue Growth

0.055

Return On Assets

0.0484

The market value of Qiagen NV is measured differently than its book value, which is the value of Qiagen that is recorded on the company's balance sheet. Investors also form their own opinion of Qiagen NV's value that differs from its market value or its book value, called intrinsic value, which is Qiagen NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Qiagen NV's market value can be influenced by many factors that don't directly affect Qiagen NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Qiagen NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Qiagen NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Qiagen NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Qiagen Nv Stock Price To Earning

Qiagen NV Company Price To Earning Analysis

P/E

Market Value Per Share

Earnings Per Share

Current Qiagen NV Price To Earning

Qiagen Price To Earning Driver Correlations

Qiagen Retained Earnings

Retained Earnings

2.58 Billion

Qiagen Price To Earning Peer Comparison

Qiagen NV Current Valuation Drivers

Qiagen NV ESG Sustainability

Qiagen Fundamentals

About Qiagen NV Fundamental Analysis

Pair Trading with Qiagen NV

Moving together with Qiagen Stock

Moving against Qiagen Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY